• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过表观遗传和翻译后修饰调控上皮-间质转化

Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.

作者信息

Serrano-Gomez Silvia Juliana, Maziveyi Mazvita, Alahari Suresh K

机构信息

Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA.

Pontificia Universidad Javeriana, Bogota, Colombia.

出版信息

Mol Cancer. 2016 Feb 24;15:18. doi: 10.1186/s12943-016-0502-x.

DOI:10.1186/s12943-016-0502-x
PMID:26905733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4765192/
Abstract

The epithelial to mesenchymal transition (EMT) is a biological process in which a non-motile epithelial cell changes to a mesenchymal phenotype with invasive capacities. This phenomenon has been well documented in multiple biological processes including embryogenesis, fibrosis, tumor progression and metastasis. The hallmark of EMT is the loss of epithelial surface markers, most notably E-cadherin, and the acquisition of mesenchymal markers including vimentin and N-cadherin. The downregulation of E-cadherin during EMT can be mediated by its transcriptional repression through the binding of EMT transcription factors (EMT-TFs) such as SNAIL, SLUG and TWIST to E-boxes present in the E-cadherin promoter. Additionally, EMT-TFs can also cooperate with several enzymes to repress the expression of E-cadherin and regulate EMT at the epigenetic and post- translational level. In this review, we will focus on epigenetic and post- translational modifications that are important in EMT. In addition, we will provide an overview of the various therapeutic approaches currently being investigated to undermine EMT and hence, the metastatic progression of cancer as well.

摘要

上皮-间质转化(EMT)是一个生物学过程,在此过程中,非运动性的上皮细胞转变为具有侵袭能力的间充质表型。这种现象在包括胚胎发生、纤维化、肿瘤进展和转移在内的多个生物学过程中都有充分记录。EMT的标志是上皮表面标志物的丧失,最显著的是E-钙黏蛋白,以及获得包括波形蛋白和N-钙黏蛋白在内的间充质标志物。EMT过程中E-钙黏蛋白的下调可通过EMT转录因子(EMT-TFs)如SNAIL、SLUG和TWIST与E-钙黏蛋白启动子中存在的E盒结合而导致其转录抑制来介导。此外,EMT-TFs还可与多种酶协同作用,在表观遗传和翻译后水平抑制E-钙黏蛋白的表达并调节EMT。在本综述中,我们将重点关注在EMT中重要的表观遗传和翻译后修饰。此外,我们还将概述目前正在研究的各种治疗方法,这些方法旨在破坏EMT,从而抑制癌症的转移进程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/26efcdef6a07/12943_2016_502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/2b752ef79c66/12943_2016_502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/674431cb0be4/12943_2016_502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/f42976462af9/12943_2016_502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/81940b62f2ba/12943_2016_502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/26efcdef6a07/12943_2016_502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/2b752ef79c66/12943_2016_502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/674431cb0be4/12943_2016_502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/f42976462af9/12943_2016_502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/81940b62f2ba/12943_2016_502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a1/4765192/26efcdef6a07/12943_2016_502_Fig5_HTML.jpg

相似文献

1
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.通过表观遗传和翻译后修饰调控上皮-间质转化
Mol Cancer. 2016 Feb 24;15:18. doi: 10.1186/s12943-016-0502-x.
2
Epithelial-to-mesenchymal transition in tumor progression.肿瘤进展中的上皮-间质转化
Med Oncol. 2017 Jul;34(7):122. doi: 10.1007/s12032-017-0980-8. Epub 2017 May 30.
3
Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.上皮间质转化标志物与原发性皮肤鳞状细胞癌的转移风险增加相关,但在淋巴结转移中减弱。
J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.
4
Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.组蛋白去乙酰化酶抑制剂恩替诺特通过逆转 E-钙黏蛋白的抑制作用来逆转乳腺癌细胞的上皮间质转化。
Breast Cancer Res Treat. 2014 Jan;143(1):99-111. doi: 10.1007/s10549-013-2784-7. Epub 2013 Dec 5.
5
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.白藜芦醇通过TGF-β1/Smads信号通路介导的Snail/E-钙黏蛋白表达抑制结直肠癌上皮-间质转化。
BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.
6
Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.二甲双胍介导的上皮-间质转化逆转是由E-钙黏蛋白启动子的表观遗传变化触发的。
J Mol Med (Berl). 2016 Dec;94(12):1397-1409. doi: 10.1007/s00109-016-1455-7. Epub 2016 Aug 17.
7
Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.一种新型人类E-钙黏蛋白剪接变体的鉴定及其对上皮-间质转化相关事件影响的评估。
J Cell Physiol. 2017 Jun;232(6):1368-1386. doi: 10.1002/jcp.25622. Epub 2016 Dec 29.
8
Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.人类正常卵巢和卵巢癌组织中上皮-间充质转化标志物的改变。
Int J Oncol. 2015 Jan;46(1):272-80. doi: 10.3892/ijo.2014.2695. Epub 2014 Oct 7.
9
Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course.人垂体腺瘤中的上皮-间质转化(EMT)标志物提示临床病程。
Anticancer Res. 2015 May;35(5):2635-43.
10
Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.上皮-间质转化和癌症转移的表观遗传控制。
Exp Cell Res. 2013 Jan 15;319(2):160-9. doi: 10.1016/j.yexcr.2012.07.019. Epub 2012 Aug 1.

引用本文的文献

1
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer.驱动卵巢癌转移至实体部位和腹水的转录程序的多模态表征。
bioRxiv. 2025 Aug 27:2025.08.26.672372. doi: 10.1101/2025.08.26.672372.
2
Autophagy-driven modulation of stem cell dynamics in -induced gastric diseases in mice.自噬驱动的小鼠幽门螺杆菌诱导性胃部疾病中干细胞动力学的调节
Virulence. 2025 Dec;16(1):2551176. doi: 10.1080/21505594.2025.2551176. Epub 2025 Sep 1.
3
Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC.

本文引用的文献

1
The relevance of EMT in breast cancer metastasis: Correlation or causality?上皮-间质转化在乳腺癌转移中的相关性:是相关性还是因果关系?
FEBS Lett. 2015 Jun 22;589(14):1577-87. doi: 10.1016/j.febslet.2015.05.002. Epub 2015 May 12.
2
Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.泛素化和类泛素化修饰在前列腺癌中的作用:机制及临床意义
Int J Mol Sci. 2015 Feb 27;16(3):4560-80. doi: 10.3390/ijms16034560.
3
Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
PIVKA-II与肝癌和胰腺癌上皮及间质特征的差异关联
Int J Mol Sci. 2025 Aug 5;26(15):7581. doi: 10.3390/ijms26157581.
4
Insights into the Molecular Mechanisms and Signaling Pathways of Epithelial to Mesenchymal Transition (EMT) in the Pathophysiology of Endometriosis.子宫内膜异位症病理生理学中上皮-间质转化(EMT)的分子机制和信号通路研究进展
Int J Mol Sci. 2025 Aug 1;26(15):7460. doi: 10.3390/ijms26157460.
5
Metallothionein 1X is a tumor suppressor gene and inhibits oxidative stress and metastasis in renal cell carcinoma.金属硫蛋白1X是一种肿瘤抑制基因,可抑制肾细胞癌中的氧化应激和转移。
Discov Oncol. 2025 Aug 13;16(1):1545. doi: 10.1007/s12672-025-02949-7.
6
ZC3H13 mediates N6-methyladenosine modification of SNTB1 to promote epithelial-mesenchymal transition in gastric cancer.ZC3H13介导SNTB1的N6-甲基腺苷修饰以促进胃癌中的上皮-间质转化。
Cell Death Dis. 2025 Aug 7;16(1):596. doi: 10.1038/s41419-025-07889-2.
7
Epigenetic Drivers of Chemoresistance in Nucleobase and Nucleoside Analog Therapies.核碱基和核苷类似物疗法中化疗耐药性的表观遗传驱动因素
Biology (Basel). 2025 Jul 9;14(7):838. doi: 10.3390/biology14070838.
8
GPX3 promotes cisplatin resistance in TNBC by manipulating ROS-TGFB1-ZEB2.GPX3通过调控ROS-TGFB1-ZEB2促进三阴性乳腺癌对顺铂的耐药性。
Cell Commun Signal. 2025 Jul 25;23(1):355. doi: 10.1186/s12964-025-02356-z.
9
Comprehensive high-throughput sequencing analysis and verification of miRNAs isolated from bronchial epithelial cells undergoing radiation-induced epithelial-mesenchymal transition.对从经历辐射诱导上皮-间质转化的支气管上皮细胞中分离出的微小RNA进行全面的高通量测序分析及验证。
Sci Prog. 2025 Jul-Sep;108(3):368504251362376. doi: 10.1177/00368504251362376. Epub 2025 Jul 22.
10
Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies.上皮-间质转化在结直肠癌转移和进展中的作用:分子机制与治疗策略
Cell Death Discov. 2025 Jul 22;11(1):336. doi: 10.1038/s41420-025-02593-8.
上皮-间质转化在肿瘤进展过程中受转化生长因子-β信号通路在转录后水平调控。
Cancer Sci. 2015 May;106(5):481-8. doi: 10.1111/cas.12630. Epub 2015 Mar 9.
4
A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis.小泛素样修饰物E3连接酶PIAS1在癌症转移中的新作用。
Oncoscience. 2014 Mar 31;1(3):229-40. doi: 10.18632/oncoscience.27. eCollection 2014.
5
Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.通过转录因子的SUMO化修饰调控上皮-间质转化
Cancer Res. 2015 Jan 1;75(1):11-5. doi: 10.1158/0008-5472.CAN-14-2824. Epub 2014 Dec 18.
6
Targeting the TGFβ pathway for cancer therapy.针对癌症治疗的 TGFβ 通路。
Pharmacol Ther. 2015 Mar;147:22-31. doi: 10.1016/j.pharmthera.2014.11.001. Epub 2014 Nov 6.
7
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.SIRT1在口腔鳞状细胞癌转移中上皮-间质转化调控中的作用
Mol Cancer. 2014 Nov 26;13:254. doi: 10.1186/1476-4598-13-254.
8
δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.δEF1与DNMT1结合,并维持乳腺癌细胞中E-钙黏蛋白启动子的DNA甲基化。
Cancer Med. 2015 Jan;4(1):125-35. doi: 10.1002/cam4.347. Epub 2014 Oct 15.
9
Signaling mechanisms of the epithelial-mesenchymal transition.上皮-间质转化的信号传导机制
Sci Signal. 2014 Sep 23;7(344):re8. doi: 10.1126/scisignal.2005189.
10
PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis.PKD1 磷酸化依赖性降解 SNAIL 由 SCF-FBXO11 调控上皮间质转化和转移。
Cancer Cell. 2014 Sep 8;26(3):358-373. doi: 10.1016/j.ccr.2014.07.022.